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Electrical therapies by defibrillators (ICD) and resynchronization devices
(CRT-D – CRT-P), have demonstrated their benefits on symptoms, morbidity
and mortality in selected heart failure patients (HF). The ITHAQUE survey
aims to describe the different supports of patients in HF patients with impaired
left ventricular (LV) function (LV ejection fraction < 45%)
 
Methods:
 
 927 patients treated for HF were seen in outpatient visit with a
general cardiologist (75%) or in a tertiary center (25%). A survey of treat-
ments and follow-ups was completed by the physician. 3 groups under optimal
treatment, defined by the French Society of Cardiology (SFC) guidelines, have
been analyzed:
 
Gr1 – 
 
Class 1B (patients with ischemic cardiomyopathy and coronary
revascularization, NYHA II and III, LVEF <30%) – Class 2aB (30% 
 
Gr2 – 
 
Class 2aB (dilated cardiomyopathy, NYHA II and III, LVEF <30%)
and class 2bC (30% 
 
Gr3 – 
 
Class 1B (HF Patients, NYHA III and IV, LVEF <35% and QRS>
120 ms) 
 
Results:
 
 Of the total patients, 79 received an ICD (8.5%), 22 a CRT-D
(2.4%) and 76 a CRT-P (8.2%). On the other side, 279 patients eligible accor-
ding to the recommendations of the SFC did not receive additional treatment
with ICD or CRT (30%). Pharmacological treatment associated is mainly com-
posed of IEC (76.5%), Beta-blockers (76.6%), Diuretics (90%), anticoagulants
(80%) and Anti-arrhythmic (31%). 
Rules lifestyle modifications (77.8%) and practice of physical activity (31.2%)
are also prescribed, associated or not. 
 
Conclusion:
 
 Although the specific conditions of therapeutic patient must
be taken into account, the ITHAQUE survey did show that the electrical the-
rapies recommended by the SFC for heart failure patients with systolic dys-
function are underused. 
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Background:
 
 Chronic obstructive pulmonary disease (COPD) is an inde-
pendent risk factor for cardiovascular disease (CVD) including heart failure
(HF) and coronary arteries diseases, which are one of the leading causes of
morbidity and mortality in COPD patients. Thus, COPD could deteriorate HF
and explain the worst prognostic of the association of the two diseases.
Actually, there is no information about the real prevalence of COPD assessed
by systematic pulmonary function test in HF patients.
 
Purpose:
 
 Describe the prevalence of COPD in a systolic HF population.
 
Methods:
 
 COPD was systematically researched by pulmonary function test
in 274 patients (216 men) followed for systolic HF in the University’s Hospital
of Rangueil, Toulouse, France between April 2002 and April 2009. Degrees of
COPD were defined according to the GOLD classification.
 
Results:
 
 In the 274 systolic HF patients mean age was 61±11 years and
mean ejection fraction (EF) was 32±15 % with 130 (47 %) patients with
ischemic systolic HF. There was 112 (41 %) of COPD with 57 (20.8 %), 44
(16.1 %), 7 (2.6 %) and 4 (1.5 %) GOLD 1, 2, 3 and 4 respectively. There was
not difference between no-COPD and COPD groups in sex (77.7 vs 75.9 %
men; p=0.1) and NYHA stage (mean 2.2±0.7 vs 2.3±0.8; p=0.3) but patients
with COPD were older (66.1±11 vs 57.1±13.7 years; p<0.001) and had better
EF (33.5±9.4 vs 30.2±12.9 %; p=0.016). There was 43.8 % ischemic heart
failure in the COPD group versus 51.8 % in the no-COPD group (p=0.13) and
no-COPD group had a tendency to have more ß-blocker treatment (74.1 vs
62.5 %; p=0.051).
 
Conclusion:
 
 COPD has a high prevalence in systolic HF population but
clinical diagnostic is difficult because of the lack of specificity of dyspnoea
assessed by NYHA stage. HF patients with COPD are older and have a better
EF suggesting that dyspnoea from pulmonary disease is interpreted as a
symptom of HF.
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Background:
 
 We describe the baseline characteristics of subjects prospec-
tively recruited in the KaRen morbidity-mortality French and Swedish
registry. KaRen’s purpose is to study the impact of dyssynchrony (electrical
and/or mechanical) on the prognosis of heart failure patients with preserved
ejection fraction. 
 
Methods and results:
 
 the Karen study is an ongoing study with a minimum
follow-up of 18-month for every patient. Here, we are reporting the initial cha-
racteristics of the 268 first patients included in the registry. These heart failure
patients with preserved ejection fraction recruited in university hospitals are
old.The mean age is 76.5 years old. 43% are between 80 and 89 years old.
59% were women. 10% of them have a bundle branch block. The prevalence
of hypertension is 75%, coronary artery disease 31%, valvular heart disease
20%, atrial fibrillation 88%, pulmonary primitive disease 24%, peripheral vas-
cular disease 15%, renal insufficiency 26% (creatinine >120µmol/l). The per-
centage of death at 4-8 weeks follow-up after the inclusion is 4% (9% in
Sweden and 2 in France despite the great similarity between the other charac-
teristics of the population).
 
Conclusions:
 
 Patients in KaRen are “real world” patients with heart failure
and preserved ejection fraction. Age and atrial fibrillation are the two most
determinant characteristics of our population.
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Aim:
 
 The present study investigated possible mechanisms underlying
postischemic remodeling in diabetic hearts. Diabetes (DM) accelerates
postischaemic cardiac remodeling and increases mortality after myocar-
dial infarction. 
 
Methods:
 
 Acute myocardial infarction (AMI) was induced in rats with
type I diabetes (DM) and non diabetic rats (NDM-AMI) while sham operated
animals served as controls (SHAM). All groups were subjected to echocardio-
graphic analysis 2 weeks after infarction. 
 © Elsevier Masson SAS. All rights reserved.
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Results:
 
 AMI resulted in increased expression of 
 
β
 
-MHC and distinct
changes in cardiac function and geometry. EF% was decreased in DM-AMI as
compared to NDM-AMI. Systolic and diastolic chamber dimensions were
increased without concomitant increase in wall thickness and thus, WTI (the
ratio of LVIDd/2*Posterior Wall thickness), an index of wall stress, was signi-
ficantly increased in DM-AMI hearts. The absence of wall thickening in DM-
AMI hearts was associated with different pattern of activation of stretch
induced kinase hypertrophic signaling p38 MAPK and ERK; Phosphorylated
ERK and p38 MAPK levels were increased in NDM-AMI hearts, while were
not changed in DM-AMI as compared to non infarcted diabetic hearts (DM-
SHAM). TH administration after AMI resulted in decreased 
 
β
 
-MHC expres-
sion, increased wall thickening and normalized wall stress, while stretch
induced p38 MAPK activation was restored. 
 
Conclusions:
 
 Diabetes reduces the ability of the myocardium to adapt after
myocardial infarction by preventing the development of compensatory hyper-
trophy. This is, at least in part due to inactivation of stress induced kinase
signalling. 
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Aim:
 
 Thyroid hormone (TH) signaling is altered in response to various
stresses including myocardial ischaemia. The present study investigated poten-
tial implication of TH in the pathophysiology of postischaemic remodeling. 
 
Methods:
 
 Acute myocardial infarction was induced in rats by coronary
artery ligation (AMI). After 34 wk, n=6 animals were on congestive heart
failure (CHF) as indicated by measurements in lung and right ventricular
weight. N=7 animals were in compensated state (non-CHF) and n=8 SHAM
operated animals served as controls (SHAM). 
 
Results:
 
 Progression to congestive heart failure was characterized by
marked decrease in EF% and all other functional echocardiographic parame-
ters. Furthermore, 
 
β
 
-MHC expression was significantly increased in CHF. A
distinct pattern of TR expression was observed in the course of postischaemic
remodeling ; TR
 
α
 
1 was up-regulated and TR
 
β
 
1 was down-regulated in non–
CHF and TR
 
α
 
1 expression was markedly decreased during the transition from
non-CHF to CHF resulting in tissue hypothyroidism. Circulating T3 and T4
remained unchanged. This response was associated with marked decrease in
ERK and mTOR activation. A potential link between ERK, mTOR and TR
 
α
 
1
expression was shown in a neonatal cardiomyocytes model of PE (pheny-
lephrine) induced pathological growth. PE increased the expression of TR
 
α
 
1
in nucleus and this response was abrogated after inhibition of mTOR or ERK. 
 
Conclusion:
 
 Progression to congestive heart failure after myocardial infarction
is associated with suppressed expression of TR
 
α
 
1 and results in tissue hypothyroi-
dism. This process may at least in part be mTOR and ERK dependent.
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oxidative stress in patients with acute heart failure
 
Jean-Christophe Charniot (1), Randa Bittar (2), Jean-Paul Albertini (1),
C Cherfils (2), V Fesel-Fouqier (2), P Giral (3), M Daubord (2), Claudine
Cosson (4), Erell Guillerm (2), Dominique Bonnefont-Rousselot (2)
 
(1) CHU Avicenne, Cardiologie, Bobigny, France – (2) CHU Pitie Salpe-
triere, Paris, France – (3) UMPC University Paris 06 UMR S 939 F,
Paris, France – (4) CHU Kremlin Bicetre, Kremlin Bicêtre, France
Background:
 
 Oxidative stress (OS) in heart failure (HF) is increased and
contribute to the pathogenesis of myocardial remodeling . Vascular inflamma-
tion is involved in deterioration of HF patients, with production of cytokines,
complement and vascular cellular adhesion molecules that perpetuate the
inflammatory state. Lipoprotein-associated phospholipase A2 (Lp-PLA2)
hydrolyze phospholipids and may be involved in inflammation and atheroscle-
rosis. 
 
Aims:
 
 We studied association between Lp-PLA2 and cardiogenic shock
and the relation between Lp-PLA2 and OS markers. 
 
Methods:
 
 Inclusion criteria: CS defined by systolic BP<90 mmHg with
peripheral hypoperfusion. Exclusion criteria: pace makers or other shock etio-
logies. Cardiac (echocardiography, coronarography) and serial biological
assays were performed upon admission and at 1 month. Lp-PLA2 was
measured with turbidimetric immunoassay. To determine the OS, we
measured marker of lipid peroxidation, protein oxidation, total anti-oxidative
status and antioxidant enzymes. 
 
Results:
 
 22 consecutive patients with CS (90% men, 57.5±10.7y, LVEF
25.3±8.5%, proBNP 8540 ng/L) were included ; 7 ischemic CM, 15 dilated
CM [12 idiopathic, 2 toxic, and 1 myocarditis]. Cardiovascular risks : diabetes
(n=11), HBP (n=7), tabacco (n=9), dyslipidemia (n=8). Lp-PLA2 were signi-
ficantly elevated in population with CS (226.8±77.3 
 
μ
 
g/L), when referred to
controls (p=0.005) whatever the cardiomyopathies. Lp-PLA2 was positively
correlated with glutathione reductase but not significantly correlated with
plasma and erythrocyte malondialdehyde, plasma carbonylated proteins and
oxidized LDL; erythrocyte superoxide dismutase, glutathione peroxidase and
catalase activities; plasma 
 
α
 
-tocopherol and vitamin A, erythrocyte reduced
glutathione (GSH) and GSSG/GSH ratio.
 
Conclusion:
 
 This study showed that Lp-PLA2 does not affect OS in
plasma particularly ox-LDL. It is noteworthy that the plasma OS is not the
exact reflects of inflammation in vascular wall because the main role of Lp-
PLA2 in atherogenesis is the hydrolysis of ox-LDL, which is generated when
LDL becomes oxidized in the milieu of the artery wall.
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Background:
 
 Idiopathic dilated cardiomyopathies (IDC) frequently
develop left ventricle (LV) hypertrabeculation which bring to doubt about the
diagnostic of LV non compaction (LVNC). The high spatial resolution of car-
diac magnetic resonance imaging (CMR) allows distinguishing myocardial tra-
beculations explaining the exponential rise in the number of reports describing
LVNC.
 
Objective:
 
 To study the correlation between the LV shape and myocardial
trabeculations regarding the BNP level in a population of IDC.
 
Methods:
 
 Between November 2007 and November 2009, 48 IDC were
prospectively assessed by CMR. Patients with echocardiographic LV ejection
fraction (LVEF) > 45%, severe valvulopathy or usual criteria of LVNC were
excluded. Patients with significant coronary artery disease (coronary stenosis
> 50%) at the angiogram or subendocardium gadolinium delayed enhancement
at the CMR were considered as ischemic cardiomyopathy and were excluded.
LV end-diastolic volume (EDV) and end-systolic volume were measured by
summing cine-CMR LV short axis slice. Sphericity index (SI) was defined as
the ratio of LV end-diastolic diameter (EDD) on LV length measured respec-
tively in midventricular short axis and midventricular 4 chambers cine-CMR
views. LV trabeculation index (LVTI) was defined as the ratio of trabeculated
on compacted layers thickness in a 16-segment model excluding apex. BNP
was measured for each patient.
 
Results:
 
 Mean age was 52±14 years with 29 (60 %) men. Mean LVEF was
25±10 % with a mean indexed EDD of 37±5 mm/m
 
2
 
 and EDV of 135±45 ml/
m
 
2
 
. LVTI was not correlate with indexed EDV (r=0.14; p=0.34) and LVEF
(r=0.02, p=0.9) but it was linearly correlated with SI (r=0.26; p=0.046) and
had a tendency to have a negative correlation with BNP level (r=-0.26;
p=0.07).
 
Conclusion:
 
 These results suggest that LV myocardial trabeculation thic-
kness increases linearly with the LV shape sphericity and has a tendency to
decrease with the rise of LV pressure regime assessed by BNP level.
